Division of Nephrology, Department of Medicine, University of California San Francisco, San Francisco, California 94143, USA.
J Biol Chem. 2010 Dec 17;285(51):39905-13. doi: 10.1074/jbc.M110.161133. Epub 2010 Oct 14.
Serum- and glucocorticoid-induced kinase 1 (SGK1) is a multifunctional protein kinase that markedly influences various cellular processes such as proliferation, apoptosis, glucose metabolism, and sodium (Na(+)) transport via the epithelial Na(+) channel, ENaC. SGK1 is a short-lived protein, which is predominantly targeted to the endoplasmic reticulum (ER) to undergo rapid proteasome-mediated degradation through the ER-associated degradation (ERAD) system. We show here that the aldosterone-induced chaperone, GILZ1 (glucocorticoid-induced leucine zipper protein-1) selectively decreases SGK1 localization to ER as well as its interaction with ER-associated E3 ubiquitin ligases, HRD1 and CHIP. GILZ1 inhibits SGK1 ubiquitinylation and subsequent proteasome-mediated degradation, thereby prolonging its half-life and increasing its steady-state expression. Furthermore, comparison of the effect of GILZ1 with that of proteasome inhibition (by MG-132) supports the idea that these effects of GILZ1 are secondary to physical interaction of GILZ1 with SGK1 and enhanced recruitment of SGK1 to targets within an "ENaC regulatory complex," thus making less SGK1 available to the ERAD machinery. Finally, effects of GILZ1 knockdown and overexpression strongly support the idea that these effects of GILZ1 are functionally important for ENaC regulation. These data provide new insight into how the manifold activities of SGK1 are selectively deployed and strengthened through modulation of its molecular interactions, subcellular localization, and stability.
血清和糖皮质激素诱导激酶 1(SGK1)是一种多功能蛋白激酶,通过上皮钠通道(ENaC)显著影响多种细胞过程,如增殖、凋亡、葡萄糖代谢和钠(Na+)转运。SGK1 是一种短寿命蛋白,主要靶向内质网(ER),通过内质网相关降解(ERAD)系统快速进行蛋白酶体介导的降解。我们在这里表明,醛固酮诱导的伴侣蛋白 GILZ1(糖皮质激素诱导亮氨酸拉链蛋白-1)选择性地减少 SGK1 向 ER 的定位及其与 ER 相关 E3 泛素连接酶 HRD1 和 CHIP 的相互作用。GILZ1 抑制 SGK1 的泛素化和随后的蛋白酶体介导的降解,从而延长其半衰期并增加其稳态表达。此外,比较 GILZ1 的作用与蛋白酶体抑制(MG-132)的作用支持这样的观点,即 GILZ1 的这些作用是继发于 GILZ1 与 SGK1 的物理相互作用以及 SGK1 向“ENaC 调节复合物”内的靶标募集的增强,从而使更少的 SGK1 可用于 ERAD 机制。最后,GILZ1 敲低和过表达的效果强烈支持这样的观点,即 GILZ1 的这些作用对于 ENaC 调节具有功能重要性。这些数据提供了新的见解,即如何通过调节其分子相互作用、亚细胞定位和稳定性来选择性地部署和增强 SGK1 的多种活性。